Full Text View
Tabular View
No Study Results Posted
Related Studies
Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database
This study is ongoing, but not recruiting participants.
Study NCT01081730   Information provided by Janssen Biotech, Inc.

First Received on March 4, 2010.   Last Updated on May 7, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Psoriasis
More general conditions related to this trial
Skin Diseases
Skin Diseases, Papulosquamous
Interventions listed in this trial
anti-TNF biologics
general population
non-anti-TNF biologics
ustekinumab
systemic non-biological treatments
Additional drug interventions recognized in this trial
Antibodies, Monoclonal
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Janssen Biotech, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services